Reply to: Comments on "Adverse reactions associated with immune checkpoint inhibitors and bevacizumab: A pharmacovigilance analysis"Gu, Tianqi; Lin, Anqi; Wang, Haitao; Zhang, Jian*; Luo, Peng*Science Citation Index Expanded南方医科大学摘要-关键词-
微信 
Facebook 
分享链接 